Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Antibiotic Stewardship: Five Tips to Reduce Resistance

2.

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

3.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

4.

When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

5.

EMA Backs Breast Cancer SERD After FDA No Vote


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot